Jupiter Life Line Hospitals Limited Cash Flow Conversion Efficiency
Jupiter Life Line Hospitals Limited cash flow conversion efficiency. Based on the latest financial reports, Jupiter Life Line Hospitals Limited (JLHL) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.30 Billion ≈ $14.07 Million USD) by net assets (Rs14.51 Billion ≈ $156.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jupiter Life Line Hospitals Limited (2020–2026)
Cash flow conversion efficiency of Jupiter Life Line Hospitals Limited from 2020 to 2026. This chart illustrates how Jupiter Life Line Hospitals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jupiter Life Line Hospitals Limited share price for real-time trading data and today's change.
Jupiter Life Line Hospitals Limited Cash Flow Conversion Ratio Explained
Jupiter Life Line Hospitals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jupiter Life Line Hospitals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jupiter Life Line Hospitals Limited ranked by their cash flow conversion efficiency. Also see how much is Jupiter Life Line Hospitals Limited worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guararapes Confecções S.A
SA:GUAR3
|
0.075x |
|
Equital
TA:EQTL
|
0.020x |
|
China Petrochemical Development Corp
TW:1314
|
0.009x |
|
Jsti Group
SHE:300284
|
-0.038x |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
N/A |
|
Gentherm Inc
NASDAQ:THRM
|
0.010x |
|
Xian Xice Testing Technology Co. Ltd. A
SHE:301306
|
N/A |
|
WuXi Xinje Electric Co Ltd
SHG:603416
|
0.001x |
Annual Cash Flow Conversion Efficiency for Jupiter Life Line Hospitals Limited (2020–2026)
The table below shows the annual cash flow conversion efficiency of Jupiter Life Line Hospitals Limited from 2020 to 2026. Review Jupiter Life Line Hospitals Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs15.44 Billion ≈ $166.99 Million |
Rs2.68 Billion ≈ $28.95 Million |
0.173x | -7.17% |
| 2025-03-31 | Rs13.56 Billion ≈ $146.67 Million |
Rs2.53 Billion ≈ $27.39 Million |
0.187x | +90.61% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.39 Million |
Rs1.15 Billion ≈ $12.39 Million |
0.098x | -69.57% |
| 2023-03-31 | Rs3.64 Billion ≈ $39.36 Million |
Rs1.17 Billion ≈ $12.67 Million |
0.322x | -32.20% |
| 2022-03-31 | Rs2.88 Billion ≈ $31.19 Million |
Rs1.37 Billion ≈ $14.81 Million |
0.475x | -5.17% |
| 2021-03-31 | Rs2.46 Billion ≈ $26.65 Million |
Rs1.23 Billion ≈ $13.35 Million |
0.501x | +142.96% |
| 2020-03-31 | Rs2.37 Billion ≈ $25.60 Million |
Rs487.93 Million ≈ $5.28 Million |
0.206x | -- |
About Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT,… Read more